VesiVax® HIVgp41e Vaccine Design
Award Notice Posted
- Solicitation number
- 75N93022C00012
- Agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Awarded
- to Molecular Express, Inc.
- Set-aside
- Total Small Business
Opportunity facts
- Contract number
- 75N93022C00012 Federal contract award
- Place of performance
- Rancho Dominguez, California 90220, United States
Notice details come from SAM.gov. Updated .
About this opportunity
Molecular Express Inc. was awarded a $300,000 contract by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to design the VesiVax HIVgp41e vaccine, which targets the HIV envelope glycoprotein gp41 subunit to prevent HIV infection. The purpose of this total small business set-aside contract is for the awardee to design the VesiVax HIVgp41e vaccine for the agency within the period of performance.
Notice text
Awarded contract 75N93022C00012 to Molecular Express Inc for 300000.00 on 2022-07-01.
Notice history
6 of 8 notices listed here. See the rest on GovTribe.
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity